ExCell Bio is a global leader in the life science reagents and bio-pharmaceutical critical materials industry. The company's core business involves providing high-quality cell culture media, serum products, and residue detection kits to customers in biopharmaceuticals, cell and gene therapy, stem cell research, and scientific institutions worldwide. Their product portfolio includes fetal bovine serum, calf serum, serum-free medium, and assay kits for detecting host cell protein, host cell DNA, and other contaminants. ExCell Bio also offers services such as media formulation development, customization, and analytical methods development to support the biopharmaceutical industry. With a strong presence in China, Uruguay, Australia, and the United States, the company aims to accelerate the application of life science and technology to benefit human health.